You are here

Pharma CEOs

How big is too big for a CEO bonus target? Annoyed Shire investors have some ideas

How big is too big for a CEO bonus target? Annoyed Shire investors have some ideas

Fierce Pharma

Flemming Ornskov

Flag link:

Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs

Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs

Forbes

Vasant Narasimham

Flag link:

Hopes rise for Shire sale as Takeda CEO discusses case for deal

Hopes rise for Shire sale as Takeda CEO discusses case for deal

NASDAQ.com

Christophe Weber

Flag link:

Which Big Pharma CEOs Least Deserved Their Big Pay Increases?

Which Big Pharma CEOs Least Deserved Their Big Pay Increases?

Motley Fool

Bristol-Myers Squibb

Gilead Sciences

Flag link:

After 2016's monster bonus—and investor complaints—Valeant CEO's pay crashes from $62M to $5M

After 2016's monster bonus—and investor complaints—Valeant CEO's pay crashes from $62M to $5M

Fierce Pharma

Valeant Pharmaceuticals

Flag link:

Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz

Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz

Fierce Pharma

Teva Pharmaceutical

Flag link:

Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise

Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise

Fierce Pharma

Bristol-Myers Squibb

Giovanni Caforio

Flag link:

Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M

Revenue down? No worries for Gilead CEO Milligan as compensation swells to $15.4M

Endpoints

Gilead Sciences

Flag link:

Glaxo's Boss Looks Ready to Loosen the Straitjacket

Glaxo's Boss Looks Ready to Loosen the Straitjacket

Bloomberg

consumer health

Flag link:

Shire CEO sees Microsoft tie-up building momentum for faster rare disease diagnosis

Shire CEO sees Microsoft tie-up building momentum for faster rare disease diagnosis

Fierce Pharma

Flemming Ornskov

Flag link:

AbbVie chief racks up $22.6M in 2017 pay, complete with $600K in personal jet use

AbbVie chief racks up $22.6M in 2017 pay, complete with $600K in personal jet use

Fierce Pharma

Richard Gonzalez

Flag link:

Is Pfizer's CEO Ian Read Really Worth 61% More?

Is Pfizer's CEO Ian Read Really Worth 61% More?

Motley Fool

Flag link:

Pfizer Lifts CEO's Pay 61% to $27.9 Million With Retention Bonus

Pfizer Lifts CEO's Pay 61% to $27.9 Million With Retention Bonus

Bloomberg

Flag link:

GlaxoSmithKline chief Emma Walmsley nets $6.8M in pay in her first year at the helm

GlaxoSmithKline chief Emma Walmsley nets $6.8M in pay in her first year at the helm

Fierce Pharma

Flag link:

Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening

Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening

Fierce Pharma

Flag link:

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

Endpoints

Richard Gonzalez

Flag link:

From drugmaker to drug manager: Ex-GSK chief Andrew Witty jumps to the helm of giant Optum

From drugmaker to drug manager: Ex-GSK chief Andrew Witty jumps to the helm of giant Optum

Endpoints

Flag link:

Reckitt CEO stands by Mead Johnson deal, despite Pfizer option

Reckitt CEO stands by Mead Johnson deal, despite Pfizer option

Yahoo/Reuters

Reckitt Benckiser

consumer health

Flag link:

Merck C.E.O. Ken Frazier on Death Row Cases and the Corporate Soul

Merck C.E.O. Ken Frazier on Death Row Cases and the Corporate Soul

NY Times, NY

Kenneth Frazier

Flag link:

[video]Novo Nordisk CEO Sees Competition in U.S. Driving Down Prices

[video]Novo Nordisk CEO Sees Competition in U.S. Driving Down Prices

Bloomberg

Lars Fruergaard Jorgensen

Flag link:

Pages